Dark

Check out our API

UTMD
Utah Medical Products Inc
stock NASDAQ

Market Open

Jun 12, 2025 3:59:57 PM EDT

57.55USD+0.331%(+0.19)16,386

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jun 11, 2025 8:50:30 AM EDT

57.31USD-0.087%(-0.05)0

After-hours

Jun 9, 2025 4:00:30 PM EDT

56.99USD-0.018%(-0.01)0

OverviewHistoricalExchangesShortsNews

Oct 26, 2021

09:00AM EDT UTMD Reports Financial Performance for Third Calendar Quarter and GlobeNewswire Inc

Jul 22, 2021

09:00AM EDT UTMD Reports Financial Performance for Second Calendar Quarter and GlobeNewswire Inc

Apr 22, 2021

09:06AM EDT Utah Medical Products Q1 EPS $0.83 Down From $0.84 YoY Benzinga

09:00AM EDT via NewMediaWire -- Because of the aberration in results which began in March 2020 due to the impact of restrictions on nonessential medical procedures, Utah Medical Products, Inc. (Nasdaq: UTMD) will report 2021 quarterly income statement results compared to the same periods in both 2020 and 2019. Please see the income statement on the last page. GlobeNewswire Inc

Mar 1, 2021

10:11AM EST Utah Medical Products Terminates Shareholder Rights Agreement RTTNews

10:00AM EST Utah Medical Products Says Terminated Shareholder Rights Agreement Benzinga

10:00AM EST Utah Medical Products, Inc. Terminates its Shareholder Rights GlobeNewswire Inc

Jan 28, 2021

09:00AM EST UTMD Reports Audited Year 2020 and Fourth Quarter Financial GlobeNewswire Inc

Oct 27, 2020

09:08AM EDT Utah Medical Products Q3 EPS $0.80 Down From $0.99 YoY, Sales $10.48M Down From $12.49M YoY Benzinga

09:00AM EDT via NewMediaWire--For the third calendar quarter (3Q) and first nine months (9M) of 2020, Utah Medical Products, Inc. (Nasdaq: UTMD) reports financial results described by CEO Kevin Cornwell as follows, GlobeNewswire Inc

Jul 28, 2020

09:05AM EDT Utah Medical Products Q2 EPS $0.35 Down From $0.94 YoY, Sales $8.79M Down From $11.85M YoY Benzinga

09:00AM EDT UTMD Reports Financial Performance for Second Calendar Quarter and GlobeNewswire Inc

Share